Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lamprini Skriapa"'
Autor:
Nikolaos Trakas, Eirini Grapsa, Socrates J. Tzartos, Paraskevi Zisimopoulou, Lamprini Skriapa
Publikováno v:
Journal of Neuroimmunology. 276:150-158
Antibodies against MuSK seem to be the pathogenic factor in approximately 5–8% of myasthenia gravis (MG) patients. We aim to develop an antigen-specific therapy in which only MuSK antibodies will be removed from patients' plasma using MuSK extracel
Autor:
Erdem Tüzün, Socrates J. Tzartos, Fred D. Finkelman, Premkumar Christadoss, Nikos Trakas, Abdullah Yilmaz, Richard T. Strait, Lamprini Skriapa, Ruksana Huda, Paraskevi Zisimopoulou, Melike Küçükerden, Sevil Kabadayi
Publikováno v:
Journal of neuroimmunology.
Sera of myasthenia gravis (MG) patients with muscle-specific receptor kinase-antibody (MuSK-Ab) predominantly display the non-complement fixing IgG4 isotype. Similarly, mouse IgG1, which is the analog of human IgG4, is the predominant isotype in mice
Autor:
Canan Ulusoy, Erdem Tüzün, Socrates J. Tzartos, Güher Saruhan-Direskeneli, Premkumar Christadoss, Fred D. Finkelman, Ruksana Huda, Konstantinos Poulas, Selin Turan, Eunmi Kim, Vuslat Yilmaz, Richard T. Strait, Nikos Trakas, Athanasios Niarchos, Lamprini Skriapa, Paraskevi Zisimopoulou
Publikováno v:
Clinical immunology (Orlando, Fla.). 151(2)
Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness associated with acetylcholine receptor (AChR), muscle-specific receptor kinase (MuSK) or low-density lipoprotein receptor-related protein 4 (LRP4)-antibodies. MuSK-antib